Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes.

Schönecker S, Brendel M, Palleis C, Beyer L, Höglinger GU, Schuh E, Rauchmann BS, Sauerbeck J, Rohrer G, Sonnenfeld S, Furukawa K, Ishiki A, Okamura N, Bartenstein P, Dieterich M, Bötzel K, Danek A, Rominger A, Levin J.

Front Aging Neurosci · 2019-09-11

DOI: 10.3389/fnagi.2019.00249PMID: 31572166

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

11 C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia.

Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT.

Ann Clin Transl Neurol · 2019-09-10

DOI: 10.1002/acn3.50877PMID: 31507085

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using 18F-FDG PET imaging.

Devrome M, Casteels C, Van der Perren A, Van Laere K, Baekelandt V, Koole M.

Sci Rep · 2019-08-26

DOI: 10.1038/s41598-019-48713-0PMID: 31451742

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Synthesis and Preliminary Evaluation of [11 C]GNE-1023 as a Potent PET Probe for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease.

Chen Z, Shao T, Gao W, Fu H, Collier TL, Rong J, Deng X, Yu Q, Zhang X, Davenport AT, Daunais JB, Wey HY, Shao Y, Josephson L, Qiu WW, Liang S.

ChemMedChem · 2019-08-22

DOI: 10.1002/cmdc.201900321PMID: 31365783

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging study.

Yang YJ, Ge JJ, Liu FT, Liu ZY, Zhao J, Wu JJ, Ma Y, Zuo CT, Wang J.

Ther Adv Neurol Disord · 2019-05-23

DOI: 10.1177/1756286419851400PMID: 31205495

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations.

Fu JF, Klyuzhin I, McKenzie J, Neilson N, Shahinfard E, Dinelle K, McKeown MJ, Stoessl AJ, Sossi V.

Neuroimage Clin · 2019-05-08

DOI: 10.1016/j.nicl.2019.101856PMID: 31091502

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.

Chung SJ, Lee YH, Yoo HS, Sohn YH, Ye BS, Cha J, Lee PH.

Eur J Nucl Med Mol Imaging · 2019-04-12

DOI: 10.1007/s00259-019-04315-6PMID: 30980099

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment.

Vancea R, Simonyan K, Petracca M, Brys M, Di Rocco A, Ghilardi MF, Inglese M.

Brain Imaging Behav · 2019-02-01

DOI: 10.1007/s11682-017-9765-0PMID: 28942477

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET/CT in patients with parkinsonism.

Hong CM, Ryu HS, Ahn BC.

Am J Nucl Med Mol Imaging · 2018-12-20

PMID: 30697456

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.

Albrecht F, Ballarini T, Neumann J, Schroeter ML.

Neuroimage Clin · 2018-11-15

DOI: 10.1016/j.nicl.2018.11.004PMID: 30514656

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

PET Molecular Imaging in Familial Parkinson's Disease.

Matarazzo M, Wile D, Mackenzie M, Stoessl AJ.

Int Rev Neurobiol · 2018-10-12

DOI: 10.1016/bs.irn.2018.09.003PMID: 30409253

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

PET Molecular Imaging in Atypical Parkinsonism.

Xu Z, Arbizu J, Pavese N.

Int Rev Neurobiol · 2018-10-08

DOI: 10.1016/bs.irn.2018.09.001PMID: 30409257

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

161 makale bulundu

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes.

<sup>11</sup> C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia.

Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using <sup>18</sup>F-FDG PET imaging.

Synthesis and Preliminary Evaluation of [<sup>11</sup> C]GNE-1023 as a Potent PET Probe for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease.

Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging study.

Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations.

Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.

Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment.

Early perfusion and dopamine transporter imaging using <sup>18</sup>F-FP-CIT PET/CT in patients with parkinsonism.

FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.

PET Molecular Imaging in Familial Parkinson's Disease.

PET Molecular Imaging in Atypical Parkinsonism.

Filtreler